Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HPV Assays With Pap Smears Could Safely Lengthen Screening Intervals

This article was originally published in The Gray Sheet

Executive Summary

Use of human papillomavirus (HPV) DNA screening assays with conventional Pap smears could safely allow for women to wait longer intervals between cervical screenings, Jack Cuzick, PhD, noted in a Jan. 5 teleconference coinciding with the same-day publication of his editorial in the Journal of the American Medical Association.

You may also be interested in...



HPV Assay Adjunctive Use With Pap Test Needs U.S. Patient Data - FDA Panel

Foreign clinical data supporting human papilloma virus (HPV) testing as an adjunct to Pap smear in screening for cervical cancer need to be confirmed in U.S. studies, FDA's Microbiology Devices Panel recommended at its recent meeting in Gaithersburg, Maryland.

ASTM Developing Standard To Tackle Dried Blood On Steel Devices

ASTM International is proposing a new standard that will provide a cleaning agent formula for removing dried blood from stainless steel medical devices.

UsernamePublicRestriction

Register

ID036688

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel